Literature DB >> 11881997

Carbocyclic dinucleoside polyphosphonates: interaction with HIV reverse transcriptase and antiviral activity.

Anastasya L Khandazhinskaya1, Elena A Shirokova, Yurii S Skoblov, Lyubov S Victorova, Ludmila Ye Goryunova, Robert S Beabealashvilli, Tatyana R Pronyaeva, Nina V Fedyuk, Vladimir V Zolin, Andrey G Pokrovsky, Marina K Kukhanova.   

Abstract

Carbocyclic alpha, gamma-bis(nucleoside)-5,5'-triphosphonates and alpha, delta-bis(nucleoside)-5,5'-tetraphosphonates (Ap4A and Gp4G) analogues were shown to be a new type of terminating substrate of HIV reverse transcriptase. They effectively inhibited the DNA synthesis catalyzed by this enzyme in model cell-free systems, but their antiviral activity both in Rat1 fibroblast cell culture bearing MLV reverse transcriptase and in HIV-infected MT-4 cells was low. When a liposome delivery system was used, the antiviral efficacy of the compounds under study was increased.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11881997     DOI: 10.1021/jm011011l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131.

Authors:  Tomas Cihlar; Adrian S Ray; Constantine G Boojamra; Lijun Zhang; Hon Hui; Genevieve Laflamme; Jennifer E Vela; Deborah Grant; James Chen; Florence Myrick; Kirsten L White; Ying Gao; Kuei-Ying Lin; Janet L Douglas; Neil T Parkin; Anne Carey; Rowchanak Pakdaman; Richard L Mackman
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.